Unilever Research and Development, Vlaardingen, The Netherlands.
Eur J Nutr. 2010 Feb;49(1):27-35. doi: 10.1007/s00394-009-0045-7. Epub 2009 Jul 29.
Ingestion of tea flavonoids found in both green and black tea is linked to cardiovascular health benefits such as lowering serum lipids. Evidence for a cholesterol-lowering benefit of green or black tea consumption from human intervention studies is, however, conflicting and active components responsible for the effect have not yet been clearly identified.
In a randomized, double-blind, placebo-controlled, parallel design study the effects of ingesting a purified black tea theaflavins (TFs) powder alone or in combination with catechin (TFs/catechins) on lowering serum total (TC) and LDL-cholesterol (LDL-c) were assessed.
In total, 102 mildly to moderately hypercholesterolemic (TC and LDL-c: 5.70 +/- 0.74 and 3.97 +/- 0.61 mmol/L, respectively) subjects (67 men and 35 women) were randomly assigned to consume once daily one capsule of one of the 3 treatments: TFs (providing 77.5 mg), TFs/catechins (providing 75.0 mg TFs plus 150.0 mg catechins and 195.0 mg of other polyphenols), or placebo (cellulose).
Serum TC and LDL-c concentrations did not differ significantly among the 3 treatments as assessed at 4, 8, and 11 weeks using analysis of covariance (p = 0.1187 and p = 0.1063, respectively). Although changes over time from baseline to week 11 were significant for TC and LDL-c (p = 0.0311 and p = 0.0269, respectively), this decrease over time was seen in the TFs and placebo groups.
In this human intervention study, no statistically significant LDL-c lowering effect was seen with either TFs alone or the TFs/catechins combination as compared to placebo. Based on these findings it cannot be concluded that tea flavonoids such as theaflavins and catechins are responsible for a putative cholesterol-lowering effect of black tea, at least not with the daily dose applied in the present study.
摄入绿茶和红茶中都含有的茶类黄酮与心血管健康益处有关,例如降低血清脂质。然而,来自人体干预研究的关于绿茶或红茶消费降低胆固醇的益处的证据是相互矛盾的,负责这种效果的活性成分尚未明确确定。
在一项随机、双盲、安慰剂对照、平行设计的研究中,评估单独摄入或与儿茶素(TFs/catechins)联合摄入纯化的红茶茶黄素(TFs)粉末对降低血清总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-c)的影响。
共有 102 名轻度至中度高胆固醇血症(TC 和 LDL-c:分别为 5.70 +/- 0.74 和 3.97 +/- 0.61 mmol/L)的受试者(67 名男性和 35 名女性)被随机分配至每天服用以下 3 种治疗方法之一的胶囊:TFs(提供 77.5mg),TFs/catechins(提供 75.0mg TFs 加 150.0mg 儿茶素和 195.0mg 其他多酚),或安慰剂(纤维素)。
在 4、8 和 11 周时,使用协方差分析评估,血清 TC 和 LDL-c 浓度在 3 种治疗方法之间无显著差异(p = 0.1187 和 p = 0.1063)。尽管从基线到第 11 周的时间变化对于 TC 和 LDL-c 是显著的(p = 0.0311 和 p = 0.0269),但这种时间上的下降在 TFs 和安慰剂组中都出现了。
在这项人体干预研究中,与安慰剂相比,单独摄入 TFs 或 TFs/catechins 组合并未显示出 LDL-c 降低的统计学显著效果。基于这些发现,不能得出结论认为茶类黄酮如茶黄素和儿茶素负责红茶的潜在降胆固醇作用,至少不能用本研究中应用的每日剂量得出结论。